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Results: After 156 TAVI, 40 patients (26%) required pacemaker implanta-
tion. CV patients were more frequently implanted than ES (35% vs 19%;
p=0.03). Out of 116 non-implanted patients, 53 (46%) patients presented with
LBBB which persisted in 35 (30%) patients. QRS width increased +27ms in
post-procedure, +21ms at hospital discharge, +15ms at 1 month, +11ms at
1 year in the whole cohort. There was no clinical nor echocardiographic dif-
ference between the LBBB group and no-LBBB group. Ischemic neurological
complication were more frequent during hospitalization in the LBBB group
(8.6% vs 3.7%; p=0.007). 
On multivariate analysis, a pre-existing incomplete LBBB (OR 4.15; IC
1.31-13.11; p=0.015) and a long pre-procedure PR interval (OR 1.023; IC
1.001-1.046; p=0.038) were predictive factors of new persistent LBBB after
TAVI and a trend with CV implantation was observed (OR 2.35; IC 0.99-
5.53; p=0.051). NYHA grade was increased in the LBBB group compared to
non-LBBB group at 1 (2,1 ± 0,8 vs 1,7 ± 0,6 ; p=0.006), 6 (2,21 ± 0,7 vs
1,53±0,6 ; p=0.001) and 12 months (2.2 vs 1.7, p=0.04). 
On univariate analysis, a pre-existing atrial fibrillation (OR 2.1; IC 1.12-
4.01; p=0.021), an initial mean aortic gradient (OR 0.78; IC 0.65-0.93;
p=0.006) and new LBBB after TAVI (OR 2.06; IC 1.05-4.04; p=0.036) were
predictive factors of mortality at 12 months. On multivariate analysis, LBBB
after TAVI was an independent predictor of mortality (OR 3.52; IC 1.17-
10.58, p=0.025).
Conclusion: New-onset LBBB is frequent after TAVI and persists in a
great proportion of patients. In our study, LBBB after TAVI was an indepen-
dent predictor of mortality.
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Background: Redo tricuspid surgery may be at high risk or even contra-
indicated in patients with comorbidities. Transcatheter valve implantation
(TVI) has been recently reported in this setting. The aim of this study was to
evaluate the early and 1-year outcomes of TVI with Edwards SAPIEN XT
valves in failed tricuspid bioprostheses (BP) and ring annuloplasty (RA).
Methods and Results: TVI was performed in 6 patients for failed tricuspid
surgical valves (3 BP, 3 RA). Median patient age was 58 years, all were in
New York Heart Association (NYHA) class≥III and 5 out of 6 had previously
undergone at least 2 cardiac interventions.
The procedure was successful in the 3 patients with BP and 2 with RA; one
patient had a moderate paravalvular regurgitation at the level of the open por-
tion of a rigid incomplete ring. Otherwise, regurgitation was absent in
3 patients, trace in 1 and mild in 1. The transvalvular gradient decreased from
8 mmHg at baseline to 4 mmHg at day 7.
At 1-year follow-up, survival was 100%. Tricuspid gradients remained
stable in all but 1 patient, as well as regurgitation grades. Only 1 patient was
in NYHA class III, 2 were in class II and 3 in class I.
Conclusions: Transfemoral TVI with SAPIEN XT valves after failed tri-
cuspid surgery is feasible in selected high-risk patients, with good early and
1-year hemodynamic and clinical results. However, RA may raise issues due
to their oval shape and open configuration.
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Background: In patients undergoing transcatheter aortic valve implanta-
tion, measurement of pulmonary pressure may help to stratify the clinical risk.
However, data may lead to patient misclassification and the role of pulmonary
vascular resistance which include cardiac output has never been investigated.
Methods and Results: One hundred and seventy one consecutive patients
with significant symptomatic aortic stenosis (aortic valve area <1 cm² or
0.6 cm²/m²) who prospectively were scheduled for transaortic valve implanta-
tion, underwent preoperative right-sided heart catheterization and quantitative
Doppler echocardiography. Of these, 99 (57.9 %) had pulmonary hypertension
[invasive mean pulmonary artery pressure (PAP) ≥25mm Hg] and 40 experi-
enced cardiac events during a 1-year follow-up (readmission for heart failure
in 16 patients, sudden and non-cardiac death in 24). In univariate analysis,
patients who had cardiac events exhibited a higher both peak systolic PAP
(46.9±12.1 versus 40.8±12,0mm Hg; P=0.026) and transpulmonary pressure
gradient (12.6±4.5 versus 10.1±3,7mm Hg; P=0.011), as well as increased pul-
monary vascular resistance (PVR, 2.7±1.0 vs. 2.0±0.8 WU, p = 0.002). Peak
systolic PAP>40mm Hg and PVR>2.05 WU were selected by receiver oper-
ating curve for predicting cardiac events with the best sensitivity and speci-
ficity. By multivariate Cox regression analysis, independent predictors of
cardiac events were as follows: body mass index (P=0.005), a mitral regurgi-
tation (P=0.018), and a spectrum of peak systolic PAP>40mm Hg with simul-
taneous PVR>2.05 WU compared with other patients [2.6 (1.39-4.89),
p=0.003].
Conclusions: Right heart catheterization could be useful to identify a high-
risk subset of aortic stenosis patients candidate for transcatheter aortic valve
implantation and help for clinical decision making.
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